skip to primary navigationskip to content

Case study on Department of Veterinary Medicine research informing WHO guidelines

last modified Jul 06, 2016 11:22 AM
Dr Caroline Trotter and her team at Cambridge’s Department of Veterinary Medicine have used mathematical modelling to help ensure that World Health Organisation guidelines provide the most robust and effective approach to meningitis vaccinations in Sub-Saharan Africa.

This case study is part of the new Public Health: Research into Policy pilot, which seeks to strengthen links between public health researchers at the University and policymakers. The pilot was launched by the Cambridge Institute of Public Health and the PublicHealth@Cambridge Network, and is overseen by a steering group including representatives from the Public Policy SRI and CSaP. Case studies are being added to the website throughout the lifespan of the pilot. For any enquiries related to the pilot, please contact Lauren Milden, Public Health Policy Coordinator, via


Meningitis is a devastating infection that causes the swelling of the meninges, the membranes surrounding the brain and spinal cord. It can lead to brain damage and deafness, as well as fatalities. The land mass stretching from Senegal to Ethiopia is known as the “meningitis belt” and during the past 100 years has suffered epidemics that have killed thousands and disabled even more, the bulk of victims being children and youth. Thankfully, in 2010, the MenAfriVac® vaccine was introduced. With over 235 million people immunised so far, the caseload of meningitis A has been eliminated in immunised populations.


However, Dr Trotter’s research assistant Andromachi Karachaliou and her colleagues showed that without a long-term vaccination programme, meningitis A would return to the region within 15 years. The team used mathematical modelling to examine the most effective vaccination strategy to ensure the population was protected in the long term, which informed World Health Organisation (WHO) recommendations. The success of the MenAfriVac® also changed the makeup of the meningitis threat, which prompted WHO to commission Dr Trotter to review operational thresholds for other serogroups of meningitis, which dictate timelines to act to prevent or to respond to epidemics. Dr Trotter analysed district-level surveillance data to show that initiating vaccination programmes earlier would prevent more cases of meningitis than would lowering the epidemic threshold, which led WHO to lower the alert thresholds, thus allowing more time to prepare for a rapid response once the epidemic threshold was reached.

The new Jeffrey Cheah Biomedical Centre - CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Jeffrey Cheah Bimedical Centre is now complete and home to the Cambridge Immunology Network Coordinator.


‘Fibroblast’ has been developed from a conversation between Harold Offeh and Dr Alice Denton, a scientist based at the Babraham Institute and a member of the Cambridge Immunology Network. Offeh was particularly interested in the character and roles played by particular cells in the immune system, as well as the immune system’s role as a primary source of protection and care. The film takes as a starting point microscopic images of broblast cells, an area of research for Dr Denton.

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more